Thermo Fisher Scientific (NYSE:TMO) CEO Marc Casper Sells 201 Shares

Thermo Fisher Scientific Inc. (NYSE:TMO) CEO Marc Casper sold 201 shares of Thermo Fisher Scientific stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $500.17, for a total value of $100,534.17. Following the sale, the chief executive officer directly owned 115,174 shares of the company’s stock, valued at approximately $57,606,579.58. The trade was a 0.17% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Thermo Fisher Scientific Stock Down 2.3%

TMO stock opened at $483.4280 on Friday. Thermo Fisher Scientific Inc. has a fifty-two week low of $385.46 and a fifty-two week high of $627.88. The company has a debt-to-equity ratio of 0.65, a current ratio of 1.93 and a quick ratio of 1.50. The stock has a market capitalization of $182.55 billion, a price-to-earnings ratio of 27.96, a PEG ratio of 2.64 and a beta of 0.74. The business’s fifty day moving average price is $441.06 and its two-hundred day moving average price is $458.02.

Thermo Fisher Scientific (NYSE:TMO) last announced its earnings results on Wednesday, July 23rd. The medical research company reported $5.36 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.22 by $0.14. Thermo Fisher Scientific had a net margin of 15.24% and a return on equity of 16.82%. The company had revenue of $10.86 billion during the quarter, compared to analysts’ expectations of $10.68 billion. During the same quarter in the previous year, the business posted $5.37 earnings per share. Thermo Fisher Scientific’s quarterly revenue was up 2.9% on a year-over-year basis. Thermo Fisher Scientific has set its Q3 2025 guidance at 5.460-5.510 EPS. FY 2025 guidance at 22.220-22.840 EPS. On average, equities analysts anticipate that Thermo Fisher Scientific Inc. will post 23.28 earnings per share for the current year.

Thermo Fisher Scientific Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Monday, September 15th will be issued a dividend of $0.43 per share. The ex-dividend date of this dividend is Monday, September 15th. This represents a $1.72 annualized dividend and a dividend yield of 0.4%. Thermo Fisher Scientific’s dividend payout ratio (DPR) is currently 9.95%.

Wall Street Analyst Weigh In

TMO has been the subject of several recent research reports. William Blair initiated coverage on Thermo Fisher Scientific in a research note on Monday. They issued an “outperform” rating for the company. Raymond James Financial reiterated an “outperform” rating and set a $535.00 target price (up from $525.00) on shares of Thermo Fisher Scientific in a research report on Thursday, July 24th. UBS Group raised their price target on Thermo Fisher Scientific from $460.00 to $500.00 and gave the stock a “neutral” rating in a research report on Thursday, July 24th. Scotiabank raised shares of Thermo Fisher Scientific from a “sector perform” rating to a “sector outperform” rating and set a $590.00 price objective for the company in a research report on Friday, July 11th. Finally, Hsbc Global Res lowered shares of Thermo Fisher Scientific from a “strong-buy” rating to a “hold” rating in a report on Thursday, July 24th. Sixteen analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $593.00.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. Bernard Wealth Management Corp. bought a new stake in shares of Thermo Fisher Scientific in the 4th quarter valued at about $25,000. CBIZ Investment Advisory Services LLC raised its position in shares of Thermo Fisher Scientific by 137.5% during the first quarter. CBIZ Investment Advisory Services LLC now owns 57 shares of the medical research company’s stock worth $28,000 after acquiring an additional 33 shares during the last quarter. Ameriflex Group Inc. acquired a new position in shares of Thermo Fisher Scientific in the fourth quarter worth approximately $30,000. Anderson Financial Strategies LLC bought a new stake in Thermo Fisher Scientific in the first quarter valued at approximately $30,000. Finally, Keystone Global Partners LLC bought a new position in Thermo Fisher Scientific during the 1st quarter worth approximately $31,000. 89.23% of the stock is owned by institutional investors.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.